186 related articles for article (PubMed ID: 33498551)
21. Kinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c.
Huang R; Zhang M; Rwere F; Waskell L; Ramamoorthy A
J Biol Chem; 2015 Feb; 290(8):4843-4855. PubMed ID: 25512382
[TBL] [Abstract][Full Text] [Related]
22. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
23. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain.
Iyanagi T
Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667
[TBL] [Abstract][Full Text] [Related]
24. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
25. Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase.
Grunau A; Paine MJ; Ladbury JE; Gutierrez A
Biochemistry; 2006 Feb; 45(5):1421-34. PubMed ID: 16445284
[TBL] [Abstract][Full Text] [Related]
26. Aromatic substitution of the FAD-shielding tryptophan reveals its differential role in regulating electron flux in methionine synthase reductase and cytochrome P450 reductase.
Meints CE; Simtchouk S; Wolthers KR
FEBS J; 2013 Mar; 280(6):1460-74. PubMed ID: 23332101
[TBL] [Abstract][Full Text] [Related]
27. Short-lived neutral FMN and FAD semiquinones are transient intermediates in cryo-reduced yeast NADPH-cytochrome P450 reductase.
Davydov RM; Jennings G; Hoffman BM; Podust LM
Arch Biochem Biophys; 2019 Sep; 673():108080. PubMed ID: 31445894
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
[TBL] [Abstract][Full Text] [Related]
30. Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions.
Kenaan C; Zhang H; Shea EV; Hollenberg PF
Biochemistry; 2011 May; 50(19):3957-67. PubMed ID: 21462923
[TBL] [Abstract][Full Text] [Related]
31. A large-scale comparative analysis of affinity, thermodynamics and functional characteristics of interactions of twelve cytochrome P450 isoforms and their redox partners.
Yablokov EO; Sushko TA; Ershov PV; Florinskaya AV; Gnedenko OV; Shkel TV; Grabovec IP; Strushkevich NV; Kaluzhskiy LA; Usanov SA; Gilep AA; Ivanov AS
Biochimie; 2019 Jul; 162():156-166. PubMed ID: 31034920
[TBL] [Abstract][Full Text] [Related]
32. The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners.
Esteves F; Campelo D; Gomes BC; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Front Pharmacol; 2020; 11():299. PubMed ID: 32256365
[TBL] [Abstract][Full Text] [Related]
33. Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450.
Campelo D; Esteves F; Brito Palma B; Costa Gomes B; Rueff J; Lautier T; Urban P; Truan G; Kranendonk M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563285
[TBL] [Abstract][Full Text] [Related]
34. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.
Ding S; Yao D; Deeni YY; Burchell B; Wolf CR; Friedberg T
Biochem J; 2001 Jun; 356(Pt 2):613-9. PubMed ID: 11368792
[TBL] [Abstract][Full Text] [Related]
35. [NADPH-cytochrome P450 reductase, not only the partner of cytochrome P450].
Wiśniewska A; Jagiełło K; Mazerska Z
Postepy Biochem; 2009; 55(3):272-8. PubMed ID: 19928583
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of electron flux in cytochrome P450 reductases reveals differences in rate-determining steps in plant and mammalian enzymes.
Whitelaw DA; Tonkin R; Meints CE; Wolthers KR
Arch Biochem Biophys; 2015 Oct; 584():107-15. PubMed ID: 26361974
[TBL] [Abstract][Full Text] [Related]
37. Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases.
Gutierrez A; Doehr O; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2000 Dec; 39(51):15990-9. PubMed ID: 11123926
[TBL] [Abstract][Full Text] [Related]
38. Real-time analysis of conformational control in electron transfer reactions of human cytochrome P450 reductase with cytochrome c.
Hedison TM; Hay S; Scrutton NS
FEBS J; 2015 Nov; 282(22):4357-75. PubMed ID: 26307151
[TBL] [Abstract][Full Text] [Related]
39. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
40. Blue light mediated photoreduction of the flavoprotein NADPH-cytochrome P450 reductase. A Förster-type energy transfer.
Müller-Enoch D
Z Naturforsch C J Biosci; 1997; 52(9-10):605-14. PubMed ID: 9373993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
